Bone mineral density in children and adolescent females treated with high doses of L-thyroxine.
Single-photon absorptiometry was used to assess forearm bone mineral content (BMC) at a proximal site (PBMC) and at a more distal site (DBMC) of the non-dominant distal forearm in 20 children and adolescent females taking high doses of L-thyroxine (120 micrograms/m2/day) for a period of 6-96 months for endemic goiter, Hashimoto's thyroiditis or thyroid cancer. PBMC was significantly reduced compared to controls (p < 0.002). No correlation was found between PBMC, the values of circulating thyroid hormones and the indices of tissue hyperthyroidism such as TSH and systolic time intervals (STI), suggesting that bone is a very sensitive target for thyroid hormones. Further studies are necessary to confirm our findings and to verify their clinical significance. At present, we believe that suppressive doses of L-thyroxine should be reserved for cancer patients only.